North Province, Zimbabwe. Nkayi is entirely rural, with a population of 130 000 served by 15 rural health centres, one mission hospital and one district hospital. The diagnosis and treatment of TB follow the national guidelines, 3 which are based on the WHO treatment guidelines. 8 New patients receive a standardised daily 6-month rifampicin-containing treatment regimen (2RHZE/4RH), and previously treated cases receive a standard ised daily 8-month retreatment regimen, with daily streptomycin (SM, S) injections during the fi rst 2 months along with the other oral medications at a health facility (2SRHZE/1RHZE/5RHE).* Treatment outcomes are well defi ned, 3, 8 monitored and recorded in the TB registers. There is limited resource capacity to trace patients who default from treatment.
In Zimbabwe, the patients decide on their DOT supporter after receiving counselling at the time of registration, and the initial choice of supporter continues unchanged for the full duration of anti-tuberculosis treatment. Information on the type of DOT supporter is recorded in the TB register. Antiretroviral therapy (ART) for HIV is provided in the ART clinics, with drug intake observed by a family member.
All patients registered in the two TB registers at Nkayi District Hospital and Mbuma Mission Hospital from January 1 to December 31, 2011, were included in the study.
Data variables were collected in September 2012 into a paper-based structured questionnaire from both TB registers; they included age, sex, type and category of TB, type of DOT, HIV status and TB treatment o utcomes. The data were single-entered into an electronic EpiData database version 3.1 (EpiData Association, Odense, Denmark). Categorical variables were analysed in relation to type of DOT and TB treatment outcomes using the χ 2 test, odds ratios (OR) and 95% confi dence intervals (CI), where appropriate. Levels of signifi cance were set at 5%.
Ethics approval was provided by the Medical Research Council of Zimbabwe and the Ethics Advisory Group of the International Union Against Tuberculosis and Lung Disease.
RESULTS
Of 763 TB patients registered in 2011, fewer than 10% selected health facility-based DOT, 51% selected Zimbabwe National Tuberculosis Guidelines advise that direct observation of anti-tuberculosis treatment (DOT) can be provided by a family member/relative as a last resort. In 2011, in Nkayi District, of 763 registered tuberculosis (TB) patients, 59 (8%) received health facility-based DOT, 392 (51%) received DOT from a trained community worker and 306 (40%) from a family member/relative. There were no differences in TB treatment outcomes between the three DOT groups, apart from a higher frequency rate of 'no reported outcomes' for those receiving family-based DOT. Family members should be trained to use a suitable DOT support package.
Z
imbabwe is one of the world's 22 high tuberculosis (TB) burden countries, and ⩾60% of its TB patients are infected with the human immunodefi ciency virus (HIV). 1 In 2010, the treatment success rate for new sputum smear-positive TB patients was 81%, lower than the 90% rate recommended by the new Global Plan to Stop TB. 2 The World Health Organization's (WHO's) Stop TB strategy recommends supervised treatment and support, including direct observation of treatment (DOT), ensuring that every dose of medication is swallowed under observation. The Zimbabwean National TB Guidelines recommend that DOT should be provided, in order of priority, by a health facility-based worker, a trained community worker or a family member/relative as a last resort, with the belief that untrained family members/relatives might not be the best people to perform DOT. 3 However, health facility-based DOT may be challenging due to distances travelled by patients, time spent away from home/work and transport costs. Studies in Thailand, Nepal, Malawi and Tanzania have shown that family-or community-based DOT is associated with good treatment outcomes. [4] [5] [6] [7] There is no published information on whether TB treatment outcomes are infl uenced by different types of DOT supporter in Zimbabwe. We therefore conducted this study in a district of Zimbabwe to describe 1) the number and proportions of registered TB patients receiving different types of DOT in relation to baseline characteristics and 2) the association of different types of DOT with TB treatment outcomes.
METHOD
This was a record review-based retrospective cohort study conducted in Nkayi District in Matabeleland trained community worker DOT and 40% selected family-based DOT. Baseline characteristics in relation to type of DOT are shown in Table 1 . More males, more adults and more patients previously treated for TB received DOT from health facilities compared with females, children and new patients (P < 0.01). More children and more new patients received DOT from trained community workers compared with adults and previously treated patients (P < 0.01). Types of DOT were similar in relation to HIV status and initiation on ART. TB treatment outcomes in relation to type of DOT are shown in Table 2 . The outcomes of treatment success, death, loss to follow-up and transfer-out were not signifi cantly different between the different types of DOT. However, signifi cantly more patients receiving family-based DOT did not have their outcomes recorded in the TB register compared with those who received DOT from trained community workers (OR 2.3, 95%CI 1.4-3.8, P < 0.01).
DISCUSSION
This is the fi rst study to describe different types of DOT selected by patients in Zimbabwe and to evaluate how these relate to TB treatment outcomes. Fewer than 10% of the patients opted for health facilitybased DOT, and these tended to be males, adults and those on retreatment. The latter observation is not surprising, as retreatment regimens involve daily SM injections for 2 months given at a health facility. Although Zimbabwe's National Tuberculosis Control Programme (NTP) recommends family-based DOT as a last resort, this option was taken up by 40% of the patients. TB treatment outcomes were not different between the three groups of DOT supporter, except that those receiving family-based DOT had a higher frequency of 'no outcomes' recorded in the TB register. This may be related to delays in updating TB registers from the DOT registers maintained at the peripheral health facilities, or a lack of information on deaths and defaulters. This area needs further assessment. 37 (10) 22 (6) 184 (50) 208 (52) 145 (39) 161 (41) 3 (1) 42 (8) 17 (8) 0 286 (51) 104 (52) 2 (33) 224 (40) 78 ( * Health facility-based DOT undertaken at one of the hospitals or at one of the rural health centres. TB = tuberculosis; DOT = directly observed treatment.
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The strengths of this study are that it was conducted within an NTP setting in a rural district of the country and the most recent annual treatment outcome data were used. Limitations refl ect the retrospective nature of the study, with some incomplete outcome data, and we were unable to verify in each of the three categories of DOT supporter whether anti-tuberculosis medications were truly directly observed.
The fi ndings of our study are similar to those reported in Thailand, Nepal, Malawi and Tanzania, [4] [5] [6] [7] and have implications for Zimbabwe's NTP. Patients with TB in rural areas have diffi culty in accessing health facilities, 9 and are likely to choose family or trained community workers as DOT providers. ART policy allows family members to supervise treatment, 10 and it makes sense to have TB treatment administered in a similar way. The NTP should ensure that some resources are used to better orient and support family members/relatives for DOT.
Las directrices nacionales sobre la tuberculosis (TB) en Zimbabue recomiendan que, como último recurso, un miembro de la familia nuclear o extensa se pueda encargar de la observación directa del tratamiento antituberculoso (DOT). En el 2011, en el Distrito de Nkayi se regi straron 763 pacientes con diagnóstico de TB, de los cuales 59 (8%) recibieron el DOT en un establecimiento de salud, 392 (51%) lo recibieron de un trabajador comunitario capacitado y 306 pacientes (40%) lo recibieron de un miembro de su familia nuclear o extensa. No se observaron diferencias en los desenlaces terapéuticos entre los tres grupos, con la excepción de una mayor frecuencia de desenlaces no comunicados en el grupo donde un familiar suministraba el tratamiento. Es preciso capacitar a los miembros de la familia sobre la utilización de un mó dulo apropiado de apoyo al DOT.
